Takeda Pharmaceutical Co Ltd
Veridion Score
Composite trend over time
Why is TAK moving today?
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for TAK.
TAK insider activity
Takeda Pharmaceutical Co Ltd
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for TAK.
TAK contract awards, year to date.
Public federal awards linked to this ticker.
TAK lobbying filings, year to date.
Registered lobbying filings matched to Takeda Pharmaceutical Co Ltd.